AdvisorShares Pure US Cannabis ETF (MSOS)
5.8000
+2.0400 (54.26%)
NYSE · Last Trade: Dec 13th, 9:25 AM EST
Detailed Quote
| Previous Close | 3.760 |
|---|---|
| Open | 5.060 |
| Day's Range | 4.700 - 5.990 |
| 52 Week Range | 2.020 - 6.020 |
| Volume | 89,236,463 |
| Market Cap | 7.75M |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 11,293,662 |
Chart
News & Press Releases
The cannabis industry is enjoying renewed momentum under Trump, whose administration has adopted a notably more accommodative approach toward the drug and its related products.
Via Stocktwits · December 12, 2025
The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare.
Via Stocktwits · November 26, 2025
The U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.
Via Stocktwits · November 13, 2025
Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.
Via Benzinga · November 12, 2025
Microcap Cannabis Stock VFF Is Having A ‘Trump Pump’ Moment — And Retail Traders Feel Bullish Ahead Of Q2 Earningsstocktwits.com
Via Stocktwits · August 10, 2025
The potential for cannabis reform has made investors bullish on the industry in recent weeks.
Via The Motley Fool · October 8, 2025
President Trump's social media feed put the markets in a frenzy.
Via The Motley Fool · October 1, 2025
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy.
Via Benzinga · September 29, 2025
Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago.
Via The Motley Fool · July 31, 2025
Cannabis ETFs have been hurt by a sector that didn't get the expected federal reform many investors expected over the past five years. Experts share what could come next.
Via Benzinga · June 9, 2025
Doug Kass says most cannabis stocks are ‘walking dead' — but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors.
Via Benzinga · May 15, 2025
Cannabis stocks rally, RAW opens its factory, Portugal leads EU exports, here's what happened this week.
Via Benzinga · April 25, 2025
Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet.
Via Benzinga · April 25, 2025
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, ETFs, and stocks that moved the market higher, as well as the market segments that defied the trend by moving lower.
Via Talk Markets · April 19, 2025
Via The Motley Fool · April 16, 2025
Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon."
Via Benzinga · March 27, 2025
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, ETFs, and stocks that moved the market higher, as well as the market segments that defied the trend by moving lower.
Via Talk Markets · March 15, 2025

AdvisorShares launched HVAC & Industrials ETF on Feb. 4, investing in HVAC & industrial companies for long-term growth. Portfolio includes ADRs.
Via Benzinga · February 6, 2025

Via The Motley Fool · January 22, 2025

Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.
Via Benzinga · January 15, 2025

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.
Via Benzinga · January 8, 2025

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025

Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025

Via The Motley Fool · December 31, 2024

In 2024, the cannabis landscape in the U.S. experienced some developments, though federal legalization or removal from the CSA.
Via Benzinga · December 27, 2024